Improving tumor budding reporting in colorectal cancer: a Delphi consensus study.
Colorectal cancer
Delphi study
ITBCC
Tumor budding
Journal
Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
01
12
2020
accepted:
14
02
2021
revised:
22
01
2021
pubmed:
3
3
2021
medline:
5
10
2021
entrez:
2
3
2021
Statut:
ppublish
Résumé
Tumor budding is a long-established independent adverse prognostic marker in colorectal cancer, yet methods for its assessment have varied widely. In an effort to standardize its reporting, a group of experts met in Bern, Switzerland, in 2016 to reach consensus on a single, international, evidence-based method for tumor budding assessment and reporting (International Tumor Budding Consensus Conference [ITBCC]). Tumor budding assessment using the ITBCC criteria has been validated in large cohorts of cancer patients and incorporated into several international colorectal cancer pathology and clinical guidelines. With the wider reporting of tumor budding, new issues have emerged that require further clarification. To better inform researchers and health-care professionals on these issues, an international group of experts in gastrointestinal pathology participated in a modified Delphi process to generate consensus and highlight areas requiring further research. This effort serves to re-affirm the importance of tumor budding in colorectal cancer and support its continued use in routine clinical practice.
Identifiants
pubmed: 33650042
doi: 10.1007/s00428-021-03059-9
pii: 10.1007/s00428-021-03059-9
pmc: PMC8448718
doi:
Types de publication
Consensus Development Conference
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
459-469Subventions
Organisme : KWF Kankerbestrijding
ID : 10602
Informations de copyright
© 2021. The Author(s).
Références
Histopathology. 2020 Sep;77(3):351-368
pubmed: 32358792
Mod Pathol. 2020 May;33(5):825-833
pubmed: 31844269
Ann Oncol. 2012 Oct;23(10):2479-2516
pubmed: 23012255
Hum Pathol. 2011 Dec;42(12):1833-40
pubmed: 21664647
Ann Surg Oncol. 2012 Nov;19(12):3706-12
pubmed: 22669453
Histopathology. 2021 Mar;78(4):476-484
pubmed: 33001500
Colorectal Dis. 2014 Apr;16(4):259-64
pubmed: 24118729
Hum Pathol. 2019 Jul;89:81-89
pubmed: 31054898
Int J Surg Pathol. 2019 Apr;27(2):147-158
pubmed: 29992847
Lancet. 2007 Dec 15;370(9604):2020-9
pubmed: 18083404
Virchows Arch. 2018 Aug;473(2):189-197
pubmed: 29626253
Mod Pathol. 2012 Oct;25(10):1315-25
pubmed: 22790014
Am J Clin Pathol. 2014 Sep;142(3):375-83
pubmed: 25125629
Am J Surg Pathol. 2012 Feb;36(2):193-201
pubmed: 22251938
Histopathology. 2012 Oct;61(4):562-75
pubmed: 22765314
Am J Surg Pathol. 2018 Jun;42(6):705-714
pubmed: 29624511
Br J Cancer. 2020 Sep;123(5):700-708
pubmed: 32601463
Nat Rev Clin Oncol. 2021 Feb;18(2):101-115
pubmed: 32901132
Int J Clin Oncol. 2020 Jan;25(1):1-42
pubmed: 31203527
Mod Pathol. 2013 Feb;26(2):295-301
pubmed: 23018875
Pathol Int. 2016 Feb;66(2):75-82
pubmed: 26753834
Hum Pathol. 2013 May;44(5):697-705
pubmed: 23159156
Mod Pathol. 2017 Sep;30(9):1299-1311
pubmed: 28548122
Am J Surg Pathol. 2009 Nov;33(11):1601-7
pubmed: 19574884
Hum Pathol. 2017 Jul;65:62-70
pubmed: 28438617
Virchows Arch. 2015 May;466(5):485-93
pubmed: 25701480
Am J Surg Pathol. 2010 May;34(5):746-8
pubmed: 20414097
Histopathology. 2020 Mar;76(4):603-612
pubmed: 31643099
Histopathology. 2019 Oct;75(4):517-525
pubmed: 31081121
J Korean Med Sci. 2017 Oct;32(10):1595-1602
pubmed: 28875602
Dis Colon Rectum. 2003 Oct;46(10):1400-6
pubmed: 14530682
Histopathology. 2012 Sep;61(3):488-96
pubmed: 22463746
Front Med (Lausanne). 2019 Oct 31;6:247
pubmed: 31737639
J Clin Oncol. 2019 Aug 1;37(22):1886-1894
pubmed: 31180819
Hum Pathol. 2019 Mar;85:145-151
pubmed: 30428391
J Gastrointest Cancer. 2015 Sep;46(3):212-8
pubmed: 25994502
Endoscopy. 2013 Oct;45(10):827-34
pubmed: 23884793
Ann Surg Oncol. 2019 Dec;26(13):4397-4404
pubmed: 31605345